GGHC
ENFN

Gilder Gagnon Howe & Co’s Enfusion, Inc. ENFN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,233
Closed -$394K – 273
2024
Q4 		$394K Sell
38,233
-18,532
-33% -$179K ﹤0.01% 236
2024
Q3 		$539K Sell
56,765
-8,505
-13% -$73.4K 0.01% 228
2024
Q2 		$556K Buy
65,270
+10,351
+19% +$94.7K 0.01% 225
2024
Q1 		$508K Buy
54,919
+12,342
+29% +$109K 0.01% 243
2023
Q4 		$413K Hold
42,577
– – 0.01% 227
2023
Q3 		$382K Buy
42,577
+1,157
+3% +$11K 0.01% 235
2023
Q2 		$465K Buy
41,420
+12,347
+42% +$109K 0.01% 249
2023
Q1 		$305K Buy
29,073
+127
+0.4% +$1.4K 0.01% 230
2022
Q4 		$280K Buy
28,946
+172
+0.6% +$1.94K 0.01% 230
2022
Q3 		$355K Buy
28,774
+692
+2% +$8.44K 0.01% 232
2022
Q2 		$287K Buy
28,082
+5,583
+25% +$61.7K 0.01% 241
2022
Q1 		$286K Buy
+22,499
New +$344K ﹤0.01% 281

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Gilder Gagnon Howe & Co's ENFN Position: Q1 2025 in Review

Gilder Gagnon Howe & Co sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 38,233 shares — an estimated $394K sold.

Gilder Gagnon Howe & Co first reported a position in ENFN in Q1 2022 and held it in 12 quarters. The position peaked at $556K in Q2 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Gilder Gagnon Howe & Co reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 38,233 Enfusion, Inc. shares in Q1 2025, an estimated $394K.
  • Gilder Gagnon Howe & Co first reported a position in Enfusion, Inc. in Q1 2022 and held it in 12 quarters.
  • Gilder Gagnon Howe & Co's Enfusion, Inc. position peaked at $556K in Q2 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2025, filed 15 May 2025.